19/08/2015 - 22:00
Vemurafenib showed promising activity against several nonmelanoma cancers carrying BRAF V600 mutations in a preliminary phase II study reported online Aug. 20 in the New England Journal of Medicine....
Field of Interest: Oncology
News Feed: Internal Medicine News - Oncology